| |
|
|
|
KemPharm Inc.  
|
|
1.45 -0.02 (-0.01%) |
07-22 09:34 |
|
Open: |
1.45 |
Pre close: |
1.47 |
Target:
|
2.07 
|
|
High: |
1.45 |
Low: |
1.42 |
Resistance:
|
1.77
2.00
|
|
Volume: |
19,679 |
Market Cap: |
41M |
Support:
|
1.41
1.17
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.51
|
MACD |
MACD(12,26):
|
-0.02 |
|
MA(20): |
1.61 |
Signal(12,26,9): |
-0.00 |
|
MA(100): |
1.67 |
Stochastic Oscillator |
%K(14,3):
|
15.66  |
|
MA(250): |
2.60 |
%D(3): |
14.34 |
|
Average Volume(K) |
3-Month: |
13613
|
52-Week |
High:
|
5.47 |
|
10-Days: |
15869 |
Low: |
1.15 |
|
RSI |
RSI(14):
|
41.64 |
Change(%): |
-68.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.035 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
15.16 |
|
EPS Est. Current Year |
-2.720 |
Return on Assets (ttm) |
-101.7 |
Shares Float (M) |
18.71 |
|
EPS Est. Next Year |
-2.300 |
PEG Ratio |
0.00 |
% Held by Insiders |
11.43 |
|
EPS Est. Next Quarter |
-0.700 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
34.90 |
|
Forward EPS |
-2.040 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
809 |
|
Book Value (p.s.) |
-2.670 |
EBITDA (p.s.) |
-3.334 |
P/E |
-0.72 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-0.55 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-51.17 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-27.23 |
P/CF |
-0.44 |
|
|
|
|
|
|
